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The Journal of Immunology
Structural and Functional Analyses of the Shedding Protease
ADAM17 in HoxB8-Immortalized Macrophages and
Dendritic-like Cells
Anne-Sophie Cabron,* Karim El azzouzi,† Melanie Boss,* Philipp Arnold,‡
Jeanette Schwarz,* Marcela Rosas,x Jan Philipp Dobert,* Egor Pavlenko,*
Neele Schumacher,* Thomas Renne´,{,‖ Philip R. Taylor,x Stefan Linder,† Stefan Rose-John,*
and Friederike Zunke*
A disintegrin andmetalloproteinase (ADAM) 17 has been implicated in many shedding processes. Major substrates of ADAM17 are
TNF-a, IL-6R, and ligands of the epidermal growth factor receptor. The essential role of the protease is emphasized by the fact
that ADAM17 deficiency is lethal in mice. To study ADAM17 function in vivo, we generated viable hypomorphic ADAM17 mice
called ADAM17ex/ex mice. Recent studies indicated regulation of proteolytic ADAM17 activity by cellular processes such as
cytoplasmic phosphorylation and removal of the prodomain by furin cleavage. Maturation and thus activation of ADAM17 is
not fully understood. So far, studies of ADAM17 maturation have been mainly limited to mouse embryonic fibroblasts or transfected
cell lines relying on nonphysiologic stimuli such as phorbol esters, thus making interpretation of the results difficult in a physiologic
context. In this article, we present a robust cell system to study ADAM17 maturation and function in primary cells of the immune
system. To this end, HoxB8 conditionally immortalized macrophage precursor cell lines were derived from bone marrow of wild-type
and hypomorphic ADAM17ex/ex mice, which are devoid of measurable ADAM17 activity. ADAM17 mutants were stably expressed in
macrophage precursor cells, differentiated to macrophages under different growth factor conditions (M-CSF versus GM-CSF), and
analyzed for cellular localization, proteolytic activity, and podosome disassembly. Our study reveals maturation and activity of
ADAM17 in a more physiological-immune cell system. We show that this cell system can be further exploited for genetic modifica-
tions of ADAM17 and for studying its function in immune cells. The Journal of Immunology, 2018, 201: 000–000.
A
s a member of the a disintegrin and metalloproteinase
(ADAM) protease family, ADAM17 performs ectodo-
main shedding of diverse transmembrane proteins.
ADAM17 has been first described as key protease involved in
TNF-a shedding (1, 2). Besides TNF-a, its receptors TNFRI and
TNFRII, the IL-6R, and ligands of the epidermal growth factor
receptor have been added to the long list of, to date, more than 80
ADAM17 substrates (3). The important role of ADAM17 in vivo
is supported by the fact that deletion of the ADAM17 gene in mice
is lethal (4). To study ADAM17 function in vivo, hypomorphic
ADAM17ex/ex mice were generated, which are viable and show
∼5% residual ADAM17 expression and no measurable shedding
activity (5). Because ADAM17 substrates include membrane-
bound cytokines [e.g., TNF-a, cytokine receptors, and the membrane-
bound chemokines fractalkine and CXCL16 (6)], ADAM17
turned out to be a key regulator during inflammation. Hence,
genetic deletion of ADAM17 or pharmacologic blockade in
neutrophils and leukocytes mediated resistance to LPS-induced
endotoxemia and protected mice from otherwise lethal septic
shock (7, 8). Because ADAM17 processes the IL-6R, ADAM17
plays a decisive role in the IL-6 transsignaling pathway as part
of the immune response (9).
Despite the importance of ADAM17 in processing a large range
of substrates, the regulatory mechanisms leading to ADAM17
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activation and substrate recognition are not fully understood.
Transgenic mice overexpressing ADAM17 show no enhancement
in substrate cleavage (10), pointing toward strict regulation of
protease activity by posttranslational mechanisms. ADAM17 is
generated as a proenzyme, and the N-terminal propeptide can act
as an autoinhibitor to keep the protease in an inactive state
(11, 12). The prodomain of ADAM17 is removed by furin-like
convertases at two different sites (13): one located between the
propeptide and the metalloprotease domain (referred to as down-
stream [ds] site) and the second cleavage site found within the
prodomain (referred to as upstream [us] site), cleavage of which
has been described as a prerequisite to cleavage at the ds site (13).
Another posttranslational modification, which has been claimed
to be important for ADAM17 activity, is phosphorylation of the
cytoplasmic domain (14–18). Consequently, treatment of cells
with phorbol ester (PMA) led to an increase in ADAM17 activ-
ity (19, 20). Under physiologic conditions, phosphorylation of
ADAM17 is mediated by MAPKs (16) and polo-like kinase 2
(PLK2) at serine 794 (15). However, the importance of phos-
phorylation of the cytoplasmic tail for ADAM17 activity is under
debate because ADAM17-deficient cell lines show normal pro-
cessing of substrates after reconstitution with ADAM17 variants,
in which the entire cytoplasmic region was deleted (21–23). In
more recent studies, it was shown that ADAM17 with a short-
charged membrane-proximal stretch of 5 aa of the cytoplasmic
portion together with a protein tag showed ADAM17-shedding
activity (24, 25). Because there is ongoing discrepancy in the
field about the role and effect of the various C-terminal (CT)
deletion mutants on ADAM17 function, a recent study uses
ADAM17 variants devoid of intracellular amino acids, comparing
a complete deletion of all 133 cytoplasmic amino acids (ADAM17
DCT) with an ADAM17 mutant still exhibiting a residual stretch
of six charged amino acids of the cytoplasmic portion (ADAM17
D700) (26). Interestingly, the ADAM17 D700 variant showed
normal activity, whereas the complete deletion of the cytoplasmic
tail (ADAM17 DCT) resulted in a complete loss of shedding ac-
tivity (26). This is the reason why in this study we exclusively
focus on the function of the ADAM17 D700 variant.
Studies addressing the physiologic relevance of posttranslational
modifications of ADAM17 have been performed mainly in mouse
embryonic fibroblasts (mEF) and in human embryonic kidney
(HEK) cells with stimulation induced by the phorbol ester PMA
(13, 15, 24, 26, 27). ADAM17 activation by the nonphysiologic
stimulator PMA and analysis of mostly cell-extrinsic substrates do
not provide a natural environment for studying ADAM17 func-
tion. For instance, physiologically relevant stimuli of immune
cells include LPS and zymosan, which activate the TLR-4 and
TLR-2 as well as the dectin-1 pathway, respectively (28–30). The
main goal of the current study was to establish a robust cell model
to study ADAM17 regulation and function under more physio-
logic conditions. Because ADAM17 is a key regulator of the
immune system, we chose primary cells of the innate immune
system for our experiments. Retroviral transduction of bone
marrow–derived macrophages and bone marrow granulocytes
from wild-type (wt) and ADAM17ex/ex mice was not efficient
enough to allow for studying ADAM17 variants. Hence, we ap-
plied an approach using an estrogen-dependent HoxB8 conditional
immortalization protocol generating a macrophage precursor cell
(MØP) line (31, 32). This cell system allows stable generation
of proliferating hematopoietic progenitor cells, which can be further
differentiated by estrogen depletion and application of M-CSF
and GM-CSF (32). The generated MØP as well as the differen-
tiated mature macrophage-like cells (M-MØ) and dendritic-like
cells (GM-MØ) respond to TLR stimulation by NF-kB–induced
transcription of proinflammatory genes like TNF-a, IL-1b, and
IL-6. Moreover, these cells can be easily transduced by retroviral
vectors.
In this study, we applied this cell system to study structural
alterations of ADAM17, comparing the results to overexpression
studies in mEF and HEK cells. ADAM17ex/ex-derived HoxB8
progenitor cells were transduced with cDNAs coding for ADAM17
variants, including ADAM17 D700, ADAM17 S794A, and
the two furin cleavage–resistant mutants ADAM17 RVNG us
and RVNG ds. ADAM17-reconstituted M-MØ and GM-MØ
were examined for expression, cellular localization, and bio-
logical activity of the ADAM17 variants. Our data provide
evidence for a divergent regulation of ADAM17 protease ac-
tivity in a physiologic cellular background in which we were
able to analyze the role of ADAM17 in the disassembly of
podosomes, which might be involved in Ag sampling and
recognition (33).
Materials and Methods
cDNA constructs and cloning
Expression plasmids of murine ADAM17 mutants (S794A, D700, RVNG
ds, RVNG us) were cloned via site-directed mutagenesis PCR using the
mADAM17 in the pcDNA3.1 (+) vector template as described (15, 26).
All ADAM17 variants were cloned into the retroviral pMXs-IZ vector
(34) using the XhoI and NotI restriction site and were myc tagged at
the C terminus. All plasmids were verified by DNA sequencing (GATC
Biotech).
Cell culture
MØP were generated from bone marrow of ADAM17wt/wt and ADAM17ex/ex
mice as previously described (32, 34). Briefly, CD117-enriched bone
marrow cells (using CD117-biotin [BD Biosciences] and anti-biotin-
MACS [Miltenyi Biotec]) were infected with an estrogen-dependent
Hoxb8 pMXs retroviral vector for conditional immortalization and
cultured in RPMI 1640 medium (Thermo Fisher Scientific) containing
10% heat-inactivated FCS (PAA Laboratories), 1% penicillin/streptomycin
(Pen/Strep), b-estradiol (1 mM) (Sigma-Aldrich), GM-CSF (10 ng/ml)
(ImmunoTools), and puromycin (20 mM/ml) (Roth). After selection in
puromycin, the MØP, ADAM17-deficient cells were further transduced
with retroviral vectors coding ADAM17 variants (in pMXs-IZ vector) and
incubated with zeocin (100 mg/ml) for selection of stably transfected
cells. ADAM17-reconstituted MØP were further differentiated to M-MØ
and GM-MØ by application of M-CSF and GM-CSF, respectively, in the
absence of estrogen (see below and Fig. 2A).
mEF were isolated from E13.5 ADAM17wt/wt and ADAM17ex/ex em-
bryos and immortalized with the SV40 large T Ag as previously described
(5). HEK293T cells were purchased from DSMZ (Braunschweig, Ger-
many), and ADAM10- and ADAM17-deficient HEK cells (HEK double
knockout [dKO]) were generated via CRISPR/Cas9 system as described
(35). mEF and HEK cells were cultured in DMEM containing 10% heat-
inactivated FCS and 1% Pen/Strep.
Transfection and retroviral transduction
HEK cells were transiently transfected with polyethylenimine (PEI) in a 1:3
DNA to PEI ratio and mEF by using X-tremeGENE HP DNATransfection
Reagent (Roche) according to the manufacturer’s instructions. Retroviruses
were generated in EcoPacks (Clontech Laboratories) and transfected by
using TurboFect (Thermo Scientific). The supernatant of the transfected
EcoPacks was concentrated with Retro-X Concentrator (Clontech Labo-
ratories). The concentrated retrovirus was used to infect ADAM17ex/ex
MØP with the ADAM17 variants. The cells were incubated with the virus
and polybrene (8 mg/ml) for 3 d and selected for stable transduction by
zeocin.
MØP differentiation
For the differentiation in GM-MØ, the MØP were washed three times
with RPMI 1640 containing 10% heat-inactivated FCS and 1% Pen/Strep
and seeded at a density of 250,000 cells per well in a six-well plate
in RPMI 1640 additionally supplemented with 10 ng/ml GM-CSF. Me-
dium was changed every 2 d. On the seventh day of differentiation, the
GM-MØ were stimulated with 1 mg/ml LPS (Escherichia coli O111:B4;
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Sigma-Aldrich) or zymosan (25 mg/ml) for 12 h. For M-MØ differentia-
tion, three wash steps with RPMI 1640 containing 10% heat-inactivated
FCS and 13 Pen/Strep were applied before seeding at a density of 350,000
cells per well on a six-well plate in RPMI 1640 additionally supplemented
with 20 ng/ml M-CSF. The medium was changed every 2 d. The stimu-
lation with LPS (1 mg/ml) or zymosan (25 mg/ml) was done on day 5 of
differentiation. Cells and the supernatant were harvested on the next day.
Bright light microscopy pictures were taken during the differentiation with
a compact inverted CKX41 microscope (Olympus) equipped with a
UPLFLN objective (numerical aperture: 0.3).
ELISA
A total of 250,000 undifferentiated MØP were seeded onto a 12-well plate
and stimulated 6 h later with LPS (1 mg/ml) or zymosan (25 mg/ml) overnight.
The differentiated MØP were stimulated 12 h before harvesting. mEF cells
were seeded at a density of 200,000 cells per well on a six-well plate. After
24 h, cells were transfected as described above. On the next day, mEF were
stimulated with PMA (200 nM) for 2 h. In the cell-free supernatant IL-6,
TNF-a and soluble TNFRII were measured by ELISA, according to the
manufacturer’s instructions. The TNFRII ELISA kit was from R&D Sys-
tems. The ELISA kits for IL-6 and TNF-a were from eBioscience.
Life cell activity assay
A total of 2 3 106 ADAM10- and ADAM17-deficient HEK cells (HEK
dKO) were seeded onto a 10-cm dish and transfected the next day with PEI
(1:3 DNA/PEI ratio). The following day, cells were detached from cell
culture dish by trypsin and seeded onto a 96-well plate (2 3 105 cells per
well). The next day, the medium was replaced by phenolred-free medium,
and quenched fluorogenic peptide (Abz-LAQAVRSSSR-Dpa; TACE-
substrate IV [no. 616407; Calbiochem]) was added to a concentration of
20 mM. Cell surface activity of ADAM17 was measured in a plate reader
(Tecan Infinite 200 Pro) for 6000 s at emission 405 nm and extinction
320 nm. ADAM17 cell surface activity was determined by calculating the
area under curve of the fluorescent signal over time.
Flow cytometry
MØP suspension cells were counted, 250,000 cells were collected, and
the differentiated MØP were mechanically detached. All cells were
washed three times with ice-cold PBS and blocked for 10 min in PBS
containing 1% BSA and 1% Fc block (blocking buffer [BioLegend]) and
incubated with the fluorescence-coupled Abs diluted 1:100 in blocking
buffer for 1 h at 4˚C. Afterwards, the cell suspension was washed two
times with ice-cold PBS containing 1% BSA. The staining was fixed with
10% lysis/fixation solution (BioLegend) in distilled water for 15 min at room
temperature. Before performing flow cytometry analysis (FACS Canto II;
BD Bioscience), the cells were washed again two times with ice-cold PBS
containing 1% BSA. A total of 30,000 events were gated using the forward
scatter area (FSC-A) and forward scatter height (FSC-H) and only CD45+
cells were used for further analyses. All used markers were compensated
before the flow cytometry analysis. All data analysis was performed using
the flow cytometry analysis software FlowJo (Tree Star).
The following Abs were used: brilliant violet 510 anti-mouse CD45 (clone
30-F11; Biolegend), brilliant violet 421 anti-mouse CD115 (clone AFS98;
Biolegend), PE anti-mouse CD11b (cloneM1/70; BDBiosciences), APC anti-
mouse F4/80 (clone BM8; Biolegend), FITC anti-mouse CD11c (clone N418;
Biolegend), PE/Cy7 anti-mouse CD206 (clone C068C2; Biolegend), and
APC/Fire anti-mouse MHCII (clone M5/114.15.2; Biolegend).
For ADAM17 cell surface staining, HEK cells were transfected as described
above, harvested, and blocked in 1% BSA in PBS for 10 min at 4˚C. The MØP
were harvested via centrifugation (1000 3 g, 5 min, 4˚C), washed with PBS,
and blocked (1% BSA and 1% Fc block, 10 min, 4˚C). Afterwards, the cell
suspension was stained with the primary Ab (1:100 diluted in 1% BSA in
PBS) for 1 h at 4˚C, washed with 1% BSA in PBS, and incubated with the
secondary Ab (1:100 in 1% BSA in PBS) for 1 h at 4˚C. Before flow
cytometry analysis, the cells were washed and resuspended in 1% BSA and
PBS. To stain dead cells, the MØP suspension was incubated for 5 min with
25 ng of 7-AAD (no. 420403; Biolegend) before flow cytometry analysis.
The following Abs were used: primary Ab anti-ADAM17 10.1
(polyclonal Ab against the extracellular portion of murine ADAM17) and
secondary Ab donkey anti-rabbit IgG Alexa Fluor 488 (no. A21206;
Thermo Fisher).
Immunofluorescence analysis
A total of 250,000 MØP per well were seeded in a six-well plate on
glass cover slips. After differentiation, cells were stimulated with LPS
(1 mg/ml) or zymosan (25 mg/ml) for 12 h. HEK cells were seeded at a
density of 200,000 cells per well on a six-well plate and transfected as
described above on the following day. Twenty-four hours after transfec-
tion, the cells were stimulated with PMA (200 nM) for 2 h. Cells were
washed with PBS, fixed with 4% PFA in PBS for 15 min at room tem-
perature, and permeabilized with 0.3% Triton X-100 (Sigma-Aldrich) in
PBS for 30 min. Cells were blocked in blocking buffer (2% BSA, 5% heat-
inactivated FCS, and 0.3% Triton in PBS) for 60 min. The primary Abs
were diluted in blocking buffer and incubated at 4˚C overnight. Cells were
washed three times with PBS containing 0.3% Triton X-100 and incubated
with secondary Abs diluted 1:500 in blocking buffer. Cells were washed
three times with 0.3% Triton X-100 in PBS, one time with PBS, and
stained with DAPI as part of the mounting mix consisting of DABCO
(Sigma-Aldrich) and MOWIOL (Merck Millipore). Stained cells were
viewed and photographed with an FV1000 confocal laser scanning mi-
croscope (Olympus) equipped with a U Plan S Apo 1003 oil immersion
objective (numerical aperture: 1.40). Digital images were processed using
FV10-ASW 4.2 Viewer (Olympus). The Pearson index was used to express
colocalization of two stainings, which was calculated by an integrated tool
within the FV10-ASW software. Transfected HEK cells were marked by a
region of interest, and colocalization of two stainings was determined by
the software, resulting in values between 0 and 1. The value 1 indicates a
100% colocalization of both markers (36). Primary Abs used are as fol-
lows: anti-PDIA6 (1:750, ab11432; Abcam), anti-myc (1:250, clone 9B11
no. 2276; Cell Signal), KDEL (1:100, clone 10C3; Enzo), anti-human
ADAM17 [1:50, A300D, in-house production (37)], anti-ADAM17 10.1
(1:100), and anti-ADAM17 18.2 (1:100) (polyclonal Abs generated by
Pineda Antiko¨rper-Service, Berlin, Germany). Secondary Abs were pur-
chased from Thermo Scientific: goat-anti-mouse Alexa Fluor 488,
goat-anti-rabbit Alexa Fluor 488, goat-anti-mouse Alexa Fluor 594, and
goat-anti-rabbit Alexa Fluor 594. For staining of ADAM17 in M-MØ and
GM-MØ, the anti-myc Ab was used because stably transfected ADAM17
constructs were myc tagged at the C terminus.
Western blot analysis
Differentiated MØP, mEF, and HEK cells were mechanically detached
from the culture dish. MØP suspension cells were pelleted by centrifu-
gation (1000 3 g, 5 min, 4˚C). All cells were washed with ice-cold PBS
and lysed in lysis buffer containing 10 mM 1.10-phenanthroline (Merck
Millipore). The MØP lysis buffer contained 1% Triton X-100, 150 mM
NaCl, 50 mM Tris-HCL (pH 7.4), and two tablets of complete protease
mixture inhibitor (Roche) in 50 ml. The lysis buffer used for the mEF
and HEK cells additionally contained 1% IGEPAL (Nonidet P-40) and
2 mM EDTA. The amount of total protein was determined by BCA assay
(Thermo Scientific). Aliquots of the lysates were supplemented with 53
SDS sample buffer (0.3 M Tris-HCl, pH 6.8, 10% SDS, 50% glycerol,
20% mercaptoethanol, 5% bromophenol blue) and heat inactivated at 95˚C
for 5 min. Equal amounts (30–40 mg total protein) were separated by
SDS-PAGE and transferred to a PVDF membrane (Merck Millipore). The
following Abs were used for detection: anti-ADAM17 10.1 (polyclonal
Ab against the extracellular portion of murine ADAM17 [peptide:
CEVKPGRHFNMAKSFPNEEK]), anti-ADAM17 18.2 (polyclonal Ab
against the intracellular portion of murine ADAM17 [peptide: RLQALQ-
PAAMMPPVSAAPKL; both Pineda Antiko¨rper-Service]), anti-ADAM17
(polyclonal Ab against intracellular domain of ADAM17, ab39162;
Abcam), anti-human ADAM17 [A300D, in-house production (37)], anti-
iRhom2 (RHBDF2) (ab116139; Abcam), anti-TNFRII (ab221921; Abcam),
anti-pro–TNF-a [in-house production, kindly provided by B. Schro¨der,
Technische Universita¨t Dresden, Dresden, Germany (26)], anti-b-actin
(A5441; Sigma-Aldrich), and anti-ADAM10 (ab124695; Abcam). As sec-
ondary Abs, goat anti-rabbit HRP and goat anti-mouse HRP (both Dianova)
were used. For protein enrichment by Con A (Sigma-Aldrich) precipita-
tion, 1000 ml of cell lysate was incubated with 30-ml Con A beads over-
night at 4˚C under constant agitation. Samples were spun down for 15 min
at 4000 3 g and washed three times with PBS. The pellet was incubated
with 100 ml of PBS and 100 ml of 53 loading buffer (see above), heated to
95˚C for 10 min, and analyzed on SDS-PAGE.
Immunoprecipitation and furin assay
Cells were lysed, and protein was quantified as described above. After-
wards, 1 mg of total protein was immunoprecipitated with 3 mg of anti-
ADAM17 Ab (no. ab39162; Abcam) overnight at 4˚C. The used Protein G
Dynabeads (no. 10004D; Thermo Fisher Scientific) were blocked with 1%
BSA in PBS overnight at 4˚C. The blocked beads were added to the
lysates and incubated for 1 h at 4˚C. After three washing steps with
lysis buffer, 1 3 SDS sample buffer was added to the beads and heated
to 65˚C for 15 min. For the furin cleavage assay, the beads were incubated
in furin assay buffer (100 mM HEPES, 1 mM CaCl, 1 mM 2-ME, 0.5%
The Journal of Immunology 3
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Triton X-100) with 1 U recombinant furin (no. P8077S; New England
Biolabs) for 30 min at 30˚C. Afterwards, 5 3 SDS sample buffer was
added and boiled. The immunoprecipitated proteins were further analyzed
by Western blotting.
Electron microscopy
For scanning electron microscopy (SEM), cells were seeded on glass slides
and differentiated to the desired cell type. Subsequently, cells were fixed in
3% glutaraldehyde in PBS for 30 min prior to three times washing in PBS.
Prior to ascending ethanol steps (30, 40, 50, 70, 96, 100%), cells were fixed
in 2% osmium tetroxide for 30 min. After critical point drying and sput-
tering with gold, samples were imaged on a Philips XL20 SEM.
Analysis of podosomes
MØP were differentiated by M-CSF for 6 d and stimulated with LPS
for 24 h as described above. Subsequently, cells were fixed with 3.7%
formaldehyde, permeabilized with 0.5% Triton X-100 and PBS (pH 7.5)
for 10 min and stained for podosome markers F-actin (Alexa-Fluor-
488– or Alexa-Fluor-568–phalloidin; Molecular Probes, Eugene, OR) and
vinculin (mAb V9264, 1:500; Sigma-Aldrich) to highlight podosome
rings. CellMask Deep Red plasma membrane stain (no. C10046; Thermo
Fisher Scientific) was used to stain the cytoplasm and nuclei at a con-
centration of 2 mg/ml. Images of fixed samples were acquired with a
confocal laser-scanning microscope (DMI 6000 with a TCS SP5 AOBS
confocal point scanner; Leica) equipped with an oil-immersion HCX PL
APO 633 numerical aperture 1.4–0.6 objective. Podosome number and
cell area analysis were performed using an ImageJ (National Institutes of
Health, Bethesda, MD) macro (38). The analysis was performed with three
different donors with 30 cells for each condition (n = 3 3 30).
Protein modeling
Protein modeling was performed with Swiss Model Expasy (http://
swissmodel.expasy.org/) and the Chimera package (University of Cal-
ifornia; www.cgl.ucsf.edu/chimera).
Data analysis and statistics
All values are expressed as the mean 6 SEM. For data analysis, Excel
(Microsoft) and GraphPad Prism version 6.00 for Mac (GraphPad Soft-
ware) were used. Differences among mean values were analyzed as indi-
cated in the figure legends by two-tailed, unpaired Student t test or one-way
ANOVA, followed by a Tukey multiple comparison test using GraphPad
Prism6 software for multiple samples, when applicable. In all analyses,
the null hypothesis was rejected at p, 0.05, with *p, 0.05, **p, 0.01,
***p , 0.005, and ****p , 0.001.
Results
Functional and structural characterization of ADAM17
mutants in mEF and HEK cells
We generated four ADAM17 mutants by introducing point mu-
tations and a C-terminal truncation after residue 699, leaving a
cytoplasmic rest of 6 aa (ADAM17 D700). Two furin-resistant
mutants were generated by introduction of an RVNG motif in ei-
ther the ds (RVKR) or us (RKRD) furin cleavage site. Furthermore,
we mutated the phosphorylation site of ADAM17 by replacing Ser794
with Ala (Fig. 1A). To study posttranslational processes of ADAM17,
mutants were analyzed for expression, cellular localization, and
proteolytic activity. Initial experiments were performed in mEF and
HEK cells on an ADAM17-deficient background. mEF were ob-
tained from hypomorphic ADAM17ex/ex animals and transiently
transfected with the respective ADAM17 mutants. Equal protein
expression of all ADAM17 variants was verified by SDS-PAGE and
Western blotting using C- and N-terminal ADAM17 Abs under
unstimulated (2PMA) and stimulated (+PMA) conditions (Fig. 1B).
It should be noted that the cytoplasmic deletion mutant (D700) can
only be detected by the N-terminal ADAM17 Ab (Fig. 1B). Epitopes
of used Abs are visualized on a schematic ADAM17 protein
(Fig. 1C). For functional analysis, ADAM17-transfected mEF
were stimulated by PMA. Cell supernatants were analyzed for
endogenous TNFRII shedding by ELISA, showing an increase
in soluble TNFRII levels, indicating enhanced ADAM17 ac-
tivity in ADAM17-reconstituted mEF in comparison to mock-
transfected cells (Fig. 1D). Mutants ADAM17 RVNG ds, S794A,
and D700 exhibited higher TNFRII-shedding activities than mock
transfectants, and only the RVNG us mutant showed no protease
activity after PMA stimulation (Fig. 1D). No changes in TNFRII
protein expression were observed under the experimental conditions
used (Fig. 1E, Supplemental Fig. 1A).
We further used ADAM10/ADAM17 dKO HEK cells for
structural and functional studies of ADAM17 variants, in which
absence of ADAM10 and ADAM17 was verified by Western
blotting and immunofluorescence (Supplemental Fig. 1B, 1C).
ADAM17 expression in reconstituted HEK A10/A17 dKO cells
was verified by Western blotting (Fig. 1F, Supplemental Fig. 1D)
and immunofluorescence (Supplemental Fig. 1G). For validation
of ADAM17 bands on Western blots, three different Abs were used:
two C-terminal (18.2; Abcam) and one N-terminal (10.1; Fig. 1F,
Supplemental Fig. 1D; see also Fig. 1C). The mature form of
overexpressed ADAM17 protein (∼90 kDa) could only be detected
by Western blotting after enrichment of the protein by immuno-
precipitation with a C-terminal ADAM17 Ab (Supplemental Fig.
1E). Further, no differences in glycosylation patterns between the
different ADAM17 variants could be found as indicated by a pep-
tide-N-glycosidase F digest (Supplemental Fig. 1F).
Cell surface localization of all ADAM17 variants in HEK cells
was verified by FACS analysis, using an N-terminal Ab (Fig. 1G).
To further determine enzyme activity on the cell surface, a fluo-
rogenic peptide cleavage assay was performed, indicating activity
for all ADAM17 variants comparable to the wt except for the
RVNG us mutant (Fig. 1H). To further analyze the intracellular
localization of ADAM17 mutants before and after PMA stimu-
lation in HEK A10/A17 dKO cells, costainings with an endo-
plasmic reticulum [ER] marker were performed (Supplemental
Fig. 1G). Interestingly, highest ER colocalization was found for
the ADAM17 D700 variant under nonstimulated and stimulated
conditions (Supplemental Fig. 1G, 1H). This could indicate less
efficient trafficking of this ADAM17 mutant from the ER to other
cellular compartments, such as the cell surface, compared with the
ADAM17 wt (Supplemental Fig. 1G, 1H; see also Fig. 1G).
However, cell surface localization of the proteolytically active
ADAM17 variants seems to be sufficient for protease activity as
indicated by the TNFRII ELISA in mEF (Fig. 1D) and the fluo-
rogenic peptide cleavage assay in HEK cells (Fig. 1H). To confirm
the described furin resistance of the ADAM17 mutants (RVNG ds
and RVNG us), their maturation was analyzed by a recombinant
furin assay and Western blotting. Immunoprecipitated ADAM17
from transfected HEK A10/A17 dKO cells was incubated with
recombinant furin, resulting in the immature form of ADAM17
(∼120 kDa) and, in case of cleavage of the prodomain, a mature
∼90 kDa–sized form (Fig. 1I). Maturation of ADAM17 protein
could be observed for ADAM17 wt and surprisingly also, but to a
lesser extent, the RVNG us mutant but not for the RVNG ds mutant
(Fig. 1I). Modeling the prodomain of ADAM17 on the basis of the
adamalysin crystal structure [previously published structure PDB:
3P24 in Fig. 1J, right (39)] shows the potential orientation and
interaction of the prodomain with the catalytic domain (Fig. 1J).
Furin cleavage sites (us: aa 57–58; ds: aa 213–214) are shown in
orange (Fig. 1J), illustrating how the cleavage of the prodomain
and, thus, maturation of ADAM17 could be mediated.
The macrophage progenitor system (MØP) on
ADAM17ex/ex background
Because there still is debate and controversy on posttransla-
tional regulation processes of ADAM17, we analyzed ADAM17
4 ADAM17 IN HoxB8-IMMORTALIZED MACROPHAGE AND DENDRITIC CELLS
 by guest on N
ovem
ber 1, 2018
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
FIGURE 1. Functional and structural analyses of ADAM17 mutants in mEF and HEK cells. (A) Schematic overview of the 827-aa-long murine
ADAM17 protein subdivided in different domains and ADAM17 mutants analyzed in this study. Mutations introduced in the prodomain to generate the
RVNG ds and RVNG us mutants are indicated by red letters. The location of the S794A point mutation is indicated by a black cross, and the ADAM17 D700
mutant is truncated after aa 699. (B) Immunoblot of endogenous ADAM17 in wt mEF and transiently overexpressed (Figure legend continues)
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maturation and activity under more physiologic conditions. We
exploited a cell system of conditionally HoxB8-immortalized
macrophagic progenitor cells (MØP) (32) to study ADAM17
cellular biology. From the bone marrow of wt and ADAM17ex/ex
mice, hematopoietic stem cells were enriched by selection for
CD117 and infected with an estrogen-regulated HoxB8 expres-
sion vector, allowing proliferation of macrophage progenitors
(MØP) in the presence of estrogen (32) (Fig. 2A). The progenitor
cells can easily be transduced by retroviral vectors coding for
the different variants of ADAM17 shown in Fig. 1A. After
selection of stably transduced MØP, these were differenti-
ated into either macrophage- or dendritic-like cells by appli-
cation of M-CSF (M-MØ) or GM-CSF (GM-MØ), respectively
(Fig. 2A). First, immortalized MØP as well as differentiated
M-MØ and GM-MØ on wt or ADAM17ex/ex background were
characterized by imaging, Western blotting, and FACS anal-
ysis (Fig. 2B–E). Electron microscopy (EM) pictures verified
characteristic morphology of undifferentiated macrophagic
precursor cells, exhibiting similar size and appearance of wt
and ADAM17ex/ex-derived MØP (Fig. 2B). Furthermore, Con
A precipitation and subsequent immunoblotting confirmed
ADAM17 expression in wt but not in ADAM17ex/ex-derived
MØP (Fig. 2C). After differentiation of the precursor cells to
mature M-MØ and GM-MØ, EM pictures revealed cell type–
specific morphology of M-MØ and GM-MØ, with no differ-
ences between wt and ADAM17ex/ex-derived cells (Fig. 2D).
Further, M-MØ and GM-MØ showed increased expression
of F4/80, CD206, CD11b, and CD11c in comparison with
undifferentiated MØP (Fig. 2E). As expected, GM-CSF dif-
ferentiated cells exhibited higher expression of CD206 and
CD11c in comparison with the M-CSF differentiated cells
(Fig. 2E) (32). Interestingly, in contrast to mEF cells, in M-MØ,
ADAM17-mediated shedding of TNF-a and TNFRII could be
stimulated with the immunologically relevant stimuli LPS or
zymosan, indicating the usefulness of our cell system to study
ADAM17 activation under physiologic conditions (Supplemental
Fig. 2A, 2B).
Using genetic modification of MØP to study
ADAM17 biology
To study ADAM17 function in the precursor as well as in the
differentiated macrophage- and dendritic-like cells, MØP were
transduced with C-terminally myc-tagged ADAM17 variants de-
scribed above (Fig. 1A). Stable and equal expression of each
ADAM17 construct in the different cell lines (MØP, M-MØ, and
GM-MØ) was verified by immunoblotting with two different
C-terminal, an anti-myc, and an N-terminal ADAM17 Ab (Fig. 3A,
Supplemental Fig. 2C). Furthermore, the ability to differentiate in
M-MØ or GM-MØ after transduction with an ADAM17-encoding
cDNA was confirmed by light microscopy and FACS analysis
(Fig. 3B, Supplemental Fig. 2D). M-MØ differentiation was
monitored up to day 6, and GM-MØ differentiation was monitored
until day 8. Both time points were chosen to ensure complete
differentiation in either cell type (Fig. 3B). Undifferentiated MØP
(day 0) were suspension cells, which became adherent during
differentiation into macrophages or dendritic-like cells and grew
in monolayers (Fig. 3B). The rate of differentiation for every
ADAM17-reconstituted MØP line into M-MØ and GM-MØ
was evaluated by cell morphology analyzing shape and size using
light microscopy. Differentiation did not differ between ADAM17
mutants, indicating that this process is ADAM17 independent, and
ADAM17 mutants do not influence macrophage development
(Fig. 3B). This result was supported by FACS analyses showing
an increase in the immune cell surface markers F4/80, CD206,
CD11b, and CD11c in ADAM17-reconstituted M-MØ and GM-MØ
as compared with the precursor cells on day 6 for M-MØ and day
8 for GM-MØ (Supplemental Fig. 2D).
Analyzing function and cellular localization of ADAM17
variants in the MØP system
MØP, M-MØ, and GM-MØ expressing different ADAM17 vari-
ants were analyzed for shedding of the endogenous ADAM17
substrates TNF-a and TNFRII by ELISA after stimulation with
LPS and zymosan (Fig. 4A, 4B). To validate the assay and to
ensure efficient and identical activation of ADAM17-reconstituted
ADAM17 in mEF exhibiting an ADAM17 knockdown (ADAM17ex/ex). Cells were nonstimulated (2PMA) or stimulated with PMA for 2 h. C-terminal
(18.2) as well as N-terminal (10.1) Abs were used to detect ADAM17, indicating uniform expression of all ADAM17 mutants. The D700 can only be
detected by the N-terminal Ab. b-Actin was used as loading control. (C) Schematic model of ADAM17 protein indicating binding sites of used Abs. The
polyclonal N-terminal ADAM17 Ab 10.1 was designed against a peptide (aa 290–309) in the catalytic domain (CD). Both C-terminal Abs (ab39162 and
house-made 18.2; Abcam) are polyclonal and were designed against a cytoplasmic epitope. The 18.2 Ab was designed to bind a peptide (aa 738–757)
within the intracellular domain (ICD). (D) ELISA of endogenous TNFRII in supernatants of ADAM17
ex/ex mEF reconstituted with each respective
ADAM17 mutant, showing constitutive shedding activity (black bars) and TNFRII shedding after a 2-h PMA stimulation (gray bars). The dotted line marks
baseline TNFRII shedding (n = 3 from three individual transfections). (E) Endogenous TNFRII protein level in ADAM17
ex/ex mEF after mock transfection
and reconstitution with ADAM17 wt with and without a 2-h PMA stimulation. Signal intensity analysis of TNFRII normalized to loading control (b-actin)
indicates unchanged TNFRII level. (F) Representative immunoblot of ADAM17 mutants transiently overexpressed in ADAM10/ADAM17 double-deficient
HEK cells (HEK A10/A17 dKO) detected by a C-terminal (18.2) as well as N-terminal Ab (10.1) showing equal ADAM17 protein level. b-Actin was used
as loading control. (G) Cell surface FACS analysis of ADAM17 overexpressed in HEK A10/A17 dKO cells stained with extracellular N-terminal Ab 10.1.
Single cells (FSC-A 3 FSC-H) were gated and plotted for secondary Ab signal (Alexa Fluor 488). Bar graph shows median fluorescence intensity after
normalization to mock transfection (n = 3 from three individual transfections). (H) ADAM17 life cell surface activity assay in ADAM17-reconstituted HEK
A10/17 dKO cells by fluorogenic peptide cleavage assay. Protease activity was determined by measuring fluorescence intensity of the cleaved peptide on
living cells for 6000 s. The area under the curve of fluorescent signal over time was calculated and normalized to the mock-transfected control (n = 3 from
three individual transfections). (I) Representative Western blot of three individual experiments (anti C-terminal Ab [Abcam]) of a furin cleavage assay.
Lysates of ADAM17-transfected HEK A10/A17 dKO cells were immunoprecipitated by a C-terminal Ab (Abcam) and incubated with 1 U of recombinant
furin. Upper ADAM17 band (∼120 kDa) indicates full-length and nonfurin-processed ADAM17 form. After furin cleavage of the prodomain, the mature
ADAM17 migrates at ∼90 kDa (black arrow). (J) Protein model of ADAM17 highlighting catalytic and prodomain (gray). In orange, the us and ds furin
cleavage sites are indicated. The prodomain of ADAM17 and its orientation toward the catalytic domain were modeled on the basis of the previously
published adamalysin crystal structure [right; PDB:3P24 (39)] using Swiss Model Expasy. The red highlighted Asp194 in adamalysin is analog to the
Asp190 in the prodomain of ADAM17. Both aspartates interact with a zinc ion (orange dot). Molecular imaging was performed using UCSF Chimera. For
statistical analyses, a two-sided Student t test was used in (E), exhibiting no statistically significant differences. A one-way ANOVA followed by a Tukey
multiple comparison test was applied in (D), (G), and (H). CD, catalytic domain; DD, disintegrin domain; ICD, intracellular domain; MPD, membrane
proximal domain; PRO, prodomain; SP, signal peptide; TM, transmembrane domain. *p , 0.05, **p , 0.01, ***p , 0.005.
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cell lines by LPS and zymosan, inflammatory protein-like IL-6
as well as the chemokine (C-C motif) ligand 4 were mea-
sured, showing similar ADAM17-independent cell stimulation
(Supplemental Fig. 3A, 3B). Only the ADAM17 S794A variant
exhibited increased IL6 levels after stimulation in M-MØ
(Supplemental Fig. 3A, middle panel). To confirm that soluble
TNF-a and soluble TNFRII release resulted from ADAM17 ac-
tivity, a specific ADAM10 inhibitor (GI2540233) and a com-
bined ADAM10 and ADAM17 inhibitor (GW2802643) (40, 41)
were added to the MØP prior to stimulation. As shown in
FIGURE 2. Establishment and characterization of MØP on wt and ADAM17ex/ex background. (A) Flow diagram of protocol to establish MØP from wt
and ADAM17ex/ex mice and further differentiation to M-MØ and GM-MØ by application of M-CSF and GM-CSF. Top, Scheme of the retroviral HoxB8
expression plasmid, which is used for estrogen-dependent immortalization of CD117-positive bone marrow–derived cells. (B) Electron microscopic picture
of HoxB8-immortalized macrophage progenitor cells gained from wt and ADAM17ex/ex mice, indicating equal shape and size of MØP. Scale bar, 10 mm.
(C) Representative immunoblot of Con A–enriched ADAM17, validating protein expression in wt but not in ADAM17ex/ex MØP using an N-terminal (10.1)
Ab. (D) EM was performed on differentiated M-MØ and GM-MØ from wt and ADAM17ex/ex MØP. M-MØ from either genetic background exhibit
characteristic round cell structure, whereas the GM-MØ show a narrower cell shape with extensions. Scale bar, 20 mm. (E) FACS analysis of cell surface
markers of differentiated M-MØ and GM-MØ in wt and ADAM17ex/ex background in comparison with undifferentiated MØP. Shaded histograms represent
the receptor staining of differentiated M-MØ or GM-MØ. Bold lines indicate receptor signal of undifferentiated MØP. Signal of the receptor staining
increases according to differentiation and is independent of ADAM17 presence. The histograms are representative of plots from three independent experiments
for each marker.
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FIGURE 3. Using the MØP system to study ADAM17 function. (A) MØP with ADAM17-deficient background (ADAM17ex/ex) were stably reconstituted
with ADAM17 variants and further differentiated to M-MØ and GM-MØ. By immunoblotting, stable protein expression of each ADAM17 variant was
regularly verified using C-terminal (18.2) as well as N-terminal (10.1) Abs. The presented immunoblots are representative for at least four independent
differentiations. b-Actin was used as loading control. (B) To ensure equal and complete differentiation of MØP to M-MØ and GM-MØ, cell morphology
was monitored by light microscopy for each ADAM17-reconstituted cell line. M-CSF was applied for complete differentiation to M-MØ until day 6 (d6),
and representative pictures are shown for day 3 and day 6. Application of GM-CSF had to be continued until day 8 to ensure complete differentiation to
GM-MØ, and representative pictures were taken at day 4 and day 8. Undifferentiated MØP are suspension cells, becoming adherent during differentiation
growing in characteristic monolayers. Scale bar, 200 mm.
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Supplemental Fig. 3C, the ADAM10 inhibitor GI did not signifi-
cantly reduce shed TNF-a levels, whereas the ADAM10/ADAM17
inhibitor GW decreased TNF-a shedding when ADAM17 was
present. Further, it was verified that substrate levels (TNFRII and
TNF-a) were neither influenced by LPS stimulation nor stable
ADAM17 expression in the MØP system (Fig. 4C–E).
Constitutive shedding of TNF-a in all three monocytic cell lines
was negligible for all ADAM17 variants in comparison with the
mock-transfected control, with no ADAM17 mutant being sig-
nificantly different from wt ADAM17 (Supplemental Fig. 3D).
Interestingly, shedding of TNFRII was significantly increased for
the D700 and S794A mutants in GM-MØ under unstimulated
conditions (Supplemental Fig. 3E, right panel). After stimulation
of MØP, M-MØ, and GM-MØ with either LPS or zymosan, effi-
cient TNF-a shedding was observed in cells expressing ADAM17
wt, S794A mutant, and D700 mutant (Fig. 4A). For the two RVNG
mutants (ds and us), diminished TNF-a cleavage was found in
M-MØ and GM-MØ (Fig. 4A), underlining the importance of the
furin-mediated removal of the propeptide on the ds as well as on
the us furin cleavage site for ADAM17 activation (13). Similar
results for both RVNG mutants (ds and us) were obtained for a
second ADAM17 substrate, TNFRII (Fig. 4B). Notably, TNFRII
shedding was less efficiently activated by zymosan in all three cell
types independent of reconstituted ADAM17 variants (Fig. 4B).
Similar to TNF-a shedding (Fig. 4A), the ADAM17 D700 mutant
and the PLK2 phosphorylation-resistant S794A mutant processed
TNFRII efficiently, confirming that the C-terminal part and the
PLK2 phosphorylation site are dispensable for protease activity in
the analyzed immune cells (Fig. 4B). To further study maturation
and the role of cellular localization of ADAM17, intracellular
immunofluorescence studies were performed by costaining of
ADAM17 and ER marker protein disulfide-isomerase in differ-
entiated M-MØ and GM-MØ after LPS stimulation (Supplemental
Fig. 4). Immunofluorescent staining of M-MØ (top panel) and
GM-MØ (bottom panel) cells showed characteristic cell mor-
phology. To some extent, all ADAM17 variants (red) showed an
overlap with the ER marker protein disulfide-isomerase (green) as
well as cell surface localization (small magnification; Supplemental
Fig. 4). Judging from the results, we felt that immunofluorescence
studies were not sensitive enough to study cell surface localization
of each ADAM17 variant in detail. Thus, cell surface detection
of ADAM17 was performed in MØP by FACS analysis, as done
in HEK cells (Fig. 4F, 4G; compare Fig. 1G). After staining the
MØP with an N-terminal ADAM17 Ab and gating for single
cells and live cells (7-AAD negative), cells were plotted for
secondary Ab signals (488 nm; Fig. 4F). Interestingly, as already
indicated by immunofluorescence studies (Supplemental Fig. 4),
the ADAM17 D700 mutant was found to a lesser extent in cell
surface structures compared with all other ADAM17 mutants
and ADAM17 wt (Fig. 4G). But judging from the ELISA data,
surface localization of the ADAM17 D700 was abundant enough
for sufficient TNF-a and TNFRII shedding, which was compa-
rable to ADAM17 wt (Fig. 4A, 4B).
To study intracellular ADAM17 regulation and transport in more
detail, endogenous protein levels of the transmembrane protein
iRhom2, which has been described to be required for ADAM17
ER-to-Golgi transport, cell surface stability, and protease activity
(42, 43) were analyzed (Fig. 4H, 4I). Immunoblots of endogenous
iRhom2 revealed a similar expression of the protein in M-MØ
and GM-MØ, with slightly higher protein levels in GM-MØ
(Fig. 4H). Furthermore, immunofluorescence stainings indicated
ER as well as cell surface distribution of endogenous iRhom2
in cells of the macrophage progenitor cell system (M-MØ and
GM-MØ; Fig. 4I).
Overall, our results suggest that cleavage of the prodomain of
ADAM17 at both furin cleavage sites was required for efficient
ADAM17 activity in MØP-derived macrophage- and dendritic-like
cells, whereas the cytoplasmic tail and its posttranslational mod-
ifications seemed to be dispensable for ADAM17 function, but
might rather play a role in efficient cell surface trafficking, espe-
cially in immune cells.
Analysis of podosomes, a physiologic readout to validate
ADAM17 function in myeloid cells
Podosomes are found in cells derived from the monocyte lineage,
including macrophages and dendritic cells (44–47), and have been
suggested to be involved in cell migration and invasion (44, 45,
47). Podosomes consist of a core of F-actin, which is typically
surrounded by a ring of actin-regulatory proteins like integrins,
paxillin, vinculin, and talin (45). The requirement of ADAM17 in
TLR-induced disassembly of podosomes was reported (48). In this
study, we use podosome number and distribution as a further
physiological readout to examine ADAM17 function in myeloid
cells. Moreover, the regulatory role of the cytoplasmic tail of
ADAM17 was analyzed by studying the effect of the cytoplasmic
deletion mutant D700 on TLR-induced podosome disassembly
(Fig. 5A, 5C, 5D). To this end, ADAM17ex/ex MØP recon-
stituted with ADAM17 wt, and the D700 mutant were dif-
ferentiated to M-MØ and stimulated with the TLR-ligand LPS.
Podosomes were visualized by staining F-actin with fluorescently
labeled phalloidin and costained for a second podosome marker
(vinculin) to highlight the presence of the podosome ring structure
to distinguish them from simple actin dots (Fig. 5A, 5B). A cell
mask staining was used to visualize cell membranes (Fig. 5A), to
distinguish single cells for quantification, and to calculate cell area,
which did not change between mock-transfected and ADAM17 wt
or D700 variant (Fig. 5E). Both, number as well as density of
podosomes per cell were significantly reduced when ADAM17 wt
or the D700 mutants were reconstituted in comparison with mock-
transfected cells (Fig. 5A, 5C, 5D). This emphasizes the signifi-
cant role of ADAM17 in podosome disassembly and suggests that
a truncated ADAM17 C terminus of 6 aa is sufficient for keeping
the equilibrium of podosome assembly and disassembly in mac-
rophages (M-MØ). These data identify the MØP system as a
well-suited cell model to study podosome regulation, which also
seems to be a robust physiological readout assay for ADAM17
function in monocytic cells. The results underline the importance
of ADAM17 on podosome disassembly and thus cell motility and
normal cell function of macrophages.
Discussion
Among the ∼80 ADAM17 substrates identified so far (3), the
protease has shown to be especially important for cleavage of
many regulators involved in immune and inflammatory responses
as well as cancer development, including membrane-tethered pro–
TNF-a, both TNF-a receptors (TNFRI and TNFRII), IL-6R, li-
gands of the EGF-R (e.g., TGF-a and amphiregulin), and adhesion
molecules (e.g., L-selectin and ICAM-1) (3, 6). Because inflam-
mation is characterized by high levels of TNF-a and IL-6, and
ADAM17 is essentially involved in the regulation of both cytokine
pathways, it makes the metalloprotease a central player in in-
flammatory processes (6). Moreover, macrophages are the major
cell type releasing TNF-a (49), further pointing to ADAM17 as an
important regulator of inflammation in this cell type. In addition,
the broad substrate repertoire of ADAM17 makes it possible that
this protease is involved in pro- as well as anti-inflammatory
pathways (6). For instance, TNF-a signaling can be activated by
ADAM17-dependent release of the cytokine from the cell surface
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FIGURE 4. Analyzing function and cellular localization of ADAM17 mutants in primary immune cells. TNF-a– (A) and TNFRII– (B) shedding ELISA
of cell supernatant of stably ADAM17-reconstituted ADAM17ex/ex MØP, M-MØ, and GM-MØ after stimulation with LPS (light gray) and zymosan
(dark gray). Results are shown normalized to the mock-transfected control, and dotted lines indicate baseline shedding activity (n = 9–12, derived from
three to four independent rounds of differentiation). Representative immunoblot of the ADAM17 substrates TNFRII (C) and pro–TNF-a (D) in MØP
lysates without and after LPS stimulation. For detection of substrates, Abs targeted against cytoplasmic epitopes were used. (E) Densitometric analysis
of the ∼70-kDa-sized band of TNFRII as well as the main form of pro–TNF-a (∼35 kDa) normalized to loading control b-actin indicate no differences
of substrate level after LPS stimulation compared with unstimulated conditions (n = 3). (F and G) Cell surface staining (Figure legend continues)
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as well as attenuated by cleavage of TNFR, which act as antag-
onists of TNF-a (50). The fundamental regulatory function of
ADAM17 in governing inflammatory responses requires strict
regulation of protease activity. The cellular mechanisms of
ADAM17 maturation and activation as well as substrate recog-
nition are not completely understood. Numerous studies addressed
the role of posttranslational modifications and their impact on
ADAM17 activity. So far, most overexpression studies to analyze
the biological behavior of specific ADAM17 mutants have mainly
been performed in ADAM17-deficient mEF or HEK cells (13, 15,
24, 26, 27). These nonimmunological cell types have the disad-
vantage that heterologous substrates and nonphysiologic stimuli
need to be employed to evaluate ADAM17 function. Thus, in most
experimental setups, cells were cotransfected with ADAM17
substrates such as pro–TNF-a or TGF-a and various ADAM17
mutants, and shedding was induced by PMA (19). The differences
of ADAM17 in stably ADAM17-transfected ADAM17ex/ex MØP by FACS analysis using an N-terminal ADAM17 Ab (10.1). (F) Gating strategy for
analysis: single cells were gated (FSC-A3 FSC-H), then live cells (7-AAD negative) were separated and plotted for secondary Ab signal (Alexa Fluor 488).
(G) Median fluorescence intensity normalized to mock-transfected cells. Dotted line indicates baseline fluorescence (n = 3). (H) Immunoblot of iRhom2 in
M-MØ and GM-MØ in ADAM17-deficient background and after reconstitution with ADAM17 wt. b-Actin was used as loading control. (I) Representative
immunofluorescence staining of iRhom2 and KDEL as ER marker in M-MØ and GM-MØ. The white box shows magnification of cell surface structures.
Scale bar, 10 mm. If not indicated differently, statistical significance is shown in comparison with the respective ADAM17 wt (A and B) or mock control (G),
using a one-way ANOVA, followed by a Tukey multiple comparison test in (A), (B), and (G). A two-sided Student t test was applied in (E), exhibiting no
significant differences. *p , 0.05, **p , 0.01, ***p , 0.005, ****p , 0.001.
FIGURE 5. Podosome formation as physiological readout for ADAM17 function. (A) Podosomes were visualized by immunofluorescence stainings in
LPS-stimulated M-MØ with ADAM17-deficient background (ADAM17ex/ex) either expressing empty vector (mock), ADAM17 wt, or cytoplasmic
deletion mutant ADAM17 D700. Podosomes were visualized by staining F-actin with Alexa Fluor 488–labeled phalloidin (green), and cell membranes were
highlighted by using a CellMask staining (red) to clearly distinguish individual cells for quantification. Scale bar, 10 mm. (B) As a second marker for
podosomes, vinculin, a component of the characteristic podosome ring structure, was stained using a specific primary Ab (green). F-actin staining is shown
in red. Scale bar, 10 mm; insets: 1 mm. Quantification of podosome staining in mock, wt, and D700-reconstituted cells expressed as podosomes per cell (C)
and podosome density (podosomes/100 mm2) (D). (E) For analysis of podosome number and density, the cell area of M-MØ was determined by a cell-
surrounding white line [as shown in (A) and (B)]. No statistical difference was found between the cell area of mock, ADAM17 wt, and ADAM17 D700–
reconstituted M-MØ (n = 3 3 30; each time, 30 cells were analyzed in three independent cell differentiations). A one-way ANOVA followed by a
Tukey multiple comparison test was applied. *p , 0.05, ***p , 0.005.
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of the applied cell systems and the nonphysiological conditions
make interpretation as well as comparison of the different studies
difficult. The continuing controversy regarding the role of post-
translational events during ADAM17 activation motivated us to
establish a more physiological cell model to study ADAM17
maturation in primary cells of the immune system.
We, in this study, introduced an immune cell system on an
ADAM17-deficient background (5), which can be genetically
modified and thus was used for expression and analysis of
ADAM17 mutants. A major advantage of the HoxB8-immortalized
macrophage progenitor cell line (31, 32) is that cells can be further
differentiated into macrophage- and dendritic-like cells (M-MØ and
GM-MØ). Because these cells endogenously express immunologi-
cally relevant ADAM17 substrates like TNF-a and TNFRII, these
substrates were used as a readout for ADAM17 activity. A further
benefit of using immune cells is the possibility to work with
physiologic stimuli such as the TLR agonists LPS or zymosan.
We, in this study, verified the proteolytic activity of the
ADAM17 D700 mutant, which contains six residual intracellular
amino acids C-terminal of the transmembrane region, because in
previous studies, a complete removal of the transmembrane region
resulted in a complete inactive protease (26). The role of the cy-
toplasmic tail in function and regulation of the ADAM17 protease
is still controversially discussed in the field. A reason for the di-
vergent results published over the recent years could be the use of
various experimental set-ups, including cell systems, choice of
analyzed substrates, and the design of the ADAM17 constructs,
which often contained charged C-terminal protein tags in the
transmembrane region, as indicated by comparison of previous
studies (21–27, 51).
In this study, we analyzed the activity of the ADAM17 D700
mutant on the cell surface of HEK as well as MØP by using a
life cell activity assay. Applying the same experimental readout in
both cell lines, ADAM17 D700 was found to a lesser extent on the
cell membrane as compared with the ADAM17 wt and other
ADAM17 variants in the immune cell system (MØP). This could
indicate a role of the cytoplasmic tail for trafficking and thus cell
surface localization in immune cells compared with nonimmune
cells. However, more studies are needed to decipher a possible
regulatory impact of the cytoplasmic tail of ADAM17 and to solve
the discrepancy in the field about the role of its membrane-
proximal portion (21–26, 51).
Shedding activity of the ADAM17 D700 mutant questions the
role of intracellular phosphorylation in ADAM17 activation (24–
26). Nonetheless, phosphorylation of ADAM17 has been regarded
as a hallmark of ADAM17 activity (6, 16–18). We analyzed the
impact of PLK2-mediated phosphorylation at Ser794 on ADAM17
activity because the activity of PLK2 had been predicted to
be a regulator of ADAM17 activity (15). Thus, we analyzed
the S794A mutant and found no interference with ADAM17
activity in mEF, HEK, and in all MØP-derived cell types. Fur-
ther, this mutant was found localized at the cell membrane in
all analyzed cells.
Activation of ADAM17 by furin-dependent removal of the
autoinhibitory propeptide seems to be complex. The proprotein
convertase furin removes the prodomain within the Golgi apparatus
on the ds cleavage site, which is located between the prodomain and
the catalytic domain (11, 12). A recent study identified an additional
furin cleavage site within the prodomain (13). In our study, the
RVNG us mutant was processed by recombinant furin, although
levels of the mature (∼90 kDa) form of ADAM17 were less com-
pared with the wt (Fig. 1I). In contrast, the ADAM17 RVNG ds only
showed a small shift in protein size, which might indicate furin
cleavage at the remaining us cleavage site (Fig. 1I, 1J). Both RVNG
mutations showed impact on ADAM17 activity. In the mEF and
HEK cell system, both furin site mutants were found at the cell
surface (Fig. 1G), but the RVNG us mutant showed less proteolytic
activity (Fig. 1H) as also recently described in nonimmunological
cell lines (13). In contrast, both RVNG mutants showed little
proteolytic activity in MØP-derived cells, although located at the
cell membrane. Interestingly, it was observed earlier in COS-7
cells that inhibition of proprotein convertases had no effect on
ADAM17 shedding activity (24), indicating that the role of furin
processing of ADAM17 is not completely understood and will
have to be studied in particular in myeloid cells.
Activation of ADAM17 might be cell type–specific, depending
on the expression and availability of cofactors influencing
ADAM17 biology. Recently, iRhom2 has been described to be
such a cofactor (43, 52, 53), showing to be crucially involved in
ADAM17 trafficking, stability, and activation (42). Phosphory-
lation of the cytoplasmic tail of iRhom2 (42) might be the
reason for the dispensability of the ADAM17 cytoplasmic
portion upon PMA stimulation.
In myeloid cells, ADAM17 is critically involved in podosome
disassembly (48). In this study, we showed that the generated
MØP-derived macrophage-like cells can be used to study podo-
some disassembly. In this physiologic cell model, substrates of
ADAM17 and the disassembly mechanism involved in podosome
loss can be studied, which will be important for the functional
understanding of these actin-rich adhesion structures that are
crucial for cell migration and matrix invasiveness of macrophages
and dendritic cells (54).
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